Divergent clinical and neuropathological phenotype in a Gerstmann-Sträussler-Scheinker P102L family

Acta Neurologica Scandinavica

Volumn 126, Issue 5, 2012, Pages 315-323

  Popova, S N ^a   Tarvainen, I ^b   Capellari, S ^c   Parchi, P ^c   Hannikainen, P ^d   Pirinen, E ^e   Haapasalo, H ^f   Alafuzoff, I ^a,e  

^a UPPSALA UNIVERSITY   (Sweden)

^b Central Hospital   (Finland)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Dementia; Movement disorders; Neurodegenerative disorders; Neurogenetics; Neuropathology

Indexed keywords

LEUCINE; PRION PROTEIN; PROLINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ATAXIA; CLINICAL ARTICLE; DEMENTIA; FEMALE; FINLAND; GENE; GENE MUTATION; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; MALE; NEUROANATOMY; NEUROPATHOLOGY; PEDIGREE; PHENOTYPE; PNRP GENE; PROTEIN LOCALIZATION; SYMPTOM;

ADULT; BRAIN; FAMILY; FEMALE; FINLAND; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIONS;

EID: 84867099101     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01628.x     Document Type: Article

References (34)

1. Collins S, McLean CA, Masters CL. Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci 2001;8:387-97.
2. Brown K, Mastrianni JA. The prion diseases. J Geriatr Psychiatry Neurol 2010;23:277-98.
3. Gerstmann JS, Scheinker I. Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems.Zugleich ein Beitrag zur Frage des vorzeitigen lakalen Alterns. Z Neurol 1936;154:736-62.
4. Chi NF, Lee YC, Lu YC, Wu HM, Soong BW. Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes: clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan. J Neurol 2010;257:191-7.
5. Alzualde A, Indakoetxea B, Ferrer I, et al. A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration. J Neuropathol Exp Neurol 2010;69:789-800.
6. Colucci M, Moleres FJ, Xie ZL, et al. Gerstmann-Sträussler-Scheinker: a new phenotype with 'curly' PrP deposits. J Neuropathol Exp Neurol 2006;65:642-51.
7. Mead S. Prion disease genetics. Eur J Hum Genet 2006;14:273-81.
8. Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene phenotypic spectrum. J Neurol 2002;249:1567-82.
9. Ghetti B, Tagliavini F, Takao M, Bugiani O, Piccardo P. Hereditary prion protein amyloidoses. Clin Lab Med 2003;23:65-85, viii.
10. Barbanti P, Fabbrini G, Salvatore M, et al. Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Sträussler-Scheinker disease (PrP-P102L mutation). Neurology 1996;47:734-41.
11. Kulczycki J, Collinge J, Lojkowska W, Parnowski T, Wierzba-Bobrowicz T. Report on the first polish case of the Gerstmann-Sträussler-Scheinker syndrome. Folia Neuropathol 2001;39:27-31.
12. Bergstrom AL, Heegaard PM, Dyrbye H, Lind P, Laursen H. Localization of disease-related PrP in Danish patients with different subtypes of prion disease. Clin Neuropathol 2009;28:321-32.
13. Wadsworth JD, Joiner S, Linehan JM, et al. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain 2006;129(Pt 6):1557-69.
14. Webb TE, Poulter M, Beck J, et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 2008;131(Pt 10):2632-46.
15. Karmon Y, Kurzweil A, Lindzen E, Holmlund T, Weinstock-Guttman B. Gerstmann-Sträussler-Scheinker syndrome masquerading multiple sclerosis. J Neurol Sci 2011;309:55-7.
16. Piccardo P, Dlouhy SR, Lievens PM, et al. Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 1998;57:979-88.
17. Parchi P, Chen SG, Brown P, et al. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A 1998;95:8322-7.
18. Ishizawa K, Komori T, Shimazu T, et al. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia. Acta Neuropathol 2002;104:342-50.
19. Tanaka Y, Minematsu K, Moriyasu H, et al. A Japanese family with a variant of Gerstmann-Sträussler-Scheinker disease. J Neurol Neurosurg Psychiatry 1997;62:454-7.
20. Juvonen V, Hietala M, Kairisto V, Savontaus ML. The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population. Acta Neurol Scand 2005;111:154-62.
21. Ferrer I, Armstrong J, Capellari S, et al. Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study. Brain Pathol 2007;17:297-303.
22. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33.
23. Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 1978;101:333-44.
24. Alafuzoff I, Thal DR, Arzberger T, et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009;117:309-20.
25. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389-404.
26. Alafuzoff I, Arzberger T, Al-Sarraj S, et al. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol 2008;18:484-96.
27. Ghetti B, Tagliavini F, Giaccone G, et al. Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol 1994;8:41-8.
28. Ghetti B, Piccardo P, Frangione B, et al. Prion protein amyloidosis. Brain Pathol 1996;6:127-45.
29. Giovagnoli AR, Di Fede G, Aresi A, Reati F, Rossi G, Tagliavini F. Atypical frontotemporal dementia as a new clinical phenotype of Gerstmann-Sträussler-Scheinker disease with the PrP-P102L mutation. Description of a previously unreported Italian family. Neurol Sci 2008;29:405-10.
30. Majtenyi C, Brown P, Cervenakova L, Goldfarb LG, Tateishi J. A three-sister sibship of Gerstmann-Sträussler-Scheinker disease with a CJD phenotype. Neurology 2000;54:2133-7.
31. Furukawa H, Kitamoto T, Tanaka Y, Tateishi J. New variant prion protein in a Japanese family with Gerstmann-Sträussler syndrome. Brain Res Mol Brain Res 1995;30:385-8.
32. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 1997;18(Suppl. 4):S1-2.
33. Bianca M, Bianca S, Vecchio I, Raffaele R, Ingegnosi C, Nicoletti F. Gerstmann-Sträussler-Scheinker disease with P102L-V129 mutation: a case with psychiatric manifestations at onset. Ann Genet 2003;46:467-9.
34. Hainfellner JA, Brantner-Inthaler S, Cervenakova L, et al. The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 1995;5:201-11.